Drug
Itacitinib
Itacitinib: highest development phase Phase 2, developed by Incyte. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| Itacitinib NCT05063110 | Phase 2 | Adults Patients Having Non Severe HLH |
| itacitinib NCT01633372 | Phase 2 | MPN (Myeloproliferative Neoplasms) |
| Itacitinib NCT04071366 | Phase 2 | Cytokine Release Syndrome |
Latest
No recent events.
Follow Itacitinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.